Skip to content
The standard in sterilization process control in healthcare and pharmaceuticals
Company Status
Company Status One-Liner
IP: granted patents in USA, Canada, Australia, China, Japan, Europe, Germany, Spain, Netherlands, France, UK, and Italy
Development: functional prototype developed and tested, product-market fit evaluation ongoing
Target market launch by Q1 2025